×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VKTX – viking therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VKTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
04:03 pm
vktx
Viking Therapeutics to Participate at Upcoming Investor Conferences
Medium
Report
Viking Therapeutics to Participate at Upcoming Investor Conferences
3/4
03:38 pm
vktx
Raymond James Lowers Viking Therapeutics, Inc. (VKTX) Price Target Amid Optimistic Clinical Initiative Outlook [Yahoo! Finance]
Low
Report
Raymond James Lowers Viking Therapeutics, Inc. (VKTX) Price Target Amid Optimistic Clinical Initiative Outlook [Yahoo! Finance]
2/28
05:57 am
vktx
Viking Therapeutics (VKTX) was upgraded by BTIG Research to "strong-buy".
Low
Report
Viking Therapeutics (VKTX) was upgraded by BTIG Research to "strong-buy".
2/25
05:29 pm
vktx
Is Viking Therapeutics (VKTX) Still Attractive After Its Recent Share Price Surge [Yahoo! Finance]
Low
Report
Is Viking Therapeutics (VKTX) Still Attractive After Its Recent Share Price Surge [Yahoo! Finance]
2/24
10:43 am
vktx
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory [Yahoo! Finance]
2/20
07:28 am
vktx
Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
2/14
08:51 am
vktx
Viking Therapeutics: Full-Speed Ahead [Seeking Alpha]
Medium
Report
Viking Therapeutics: Full-Speed Ahead [Seeking Alpha]
2/13
08:37 am
vktx
Viking Therapeutics: Buyers Are Quietly Accumulating On Its Obesity Drugs Launch Potential [Seeking Alpha]
Medium
Report
Viking Therapeutics: Buyers Are Quietly Accumulating On Its Obesity Drugs Launch Potential [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
10/22/2025
04:05 pm
VKTX
viking therapeutics, inc.
MISS
Report
8.0%
viking therapeutics, inc.
4/23/2025
04:05 pm
VKTX
viking therapeutics, inc.
MISS
Report
-1.1%
viking therapeutics, inc.
Date
Time
Symbol
Headline
Impact
2/11
05:26 pm
vktx
Form 10-K Viking Therapeutics, For: Dec 31
Low
Report
Form 10-K Viking Therapeutics, For: Dec 31
2/11
04:06 pm
vktx
Form 8-K Viking Therapeutics, For: Feb 11
Medium
Report
Form 8-K Viking Therapeutics, For: Feb 11
1/26
07:57 pm
vktx
Form 4 Viking Therapeutics, For: Jan 12 Filed by: Aubuchon Neil William
Low
Report
Form 4 Viking Therapeutics, For: Jan 12 Filed by: Aubuchon Neil William
1/26
07:56 pm
vktx
Form 3 Viking Therapeutics, For: Jan 12 Filed by: Aubuchon Neil William
Low
Report
Form 3 Viking Therapeutics, For: Jan 12 Filed by: Aubuchon Neil William
1/5
08:32 pm
vktx
Form 4 Viking Therapeutics, For: Jan 02 Filed by: ZANTE GREG
Low
Report
Form 4 Viking Therapeutics, For: Jan 02 Filed by: ZANTE GREG
1/5
08:31 pm
vktx
Form 4 Viking Therapeutics, For: Jan 02 Filed by: Mancini Marianna
Low
Report
Form 4 Viking Therapeutics, For: Jan 02 Filed by: Mancini Marianna
1/5
08:28 pm
vktx
Form 4 Viking Therapeutics, For: Jan 02 Filed by: Lian Brian
Low
Report
Form 4 Viking Therapeutics, For: Jan 02 Filed by: Lian Brian
1/5
08:27 pm
vktx
Form 4 Viking Therapeutics, For: Jan 02 Filed by: SINGLETON J MATTHEW
Low
Report
Form 4 Viking Therapeutics, For: Jan 02 Filed by: SINGLETON J MATTHEW
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/5
Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
19.0%
3/19 Viking Therapeutics Inc (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at William Blair. 8.1%
5/4 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.2%
12/21 Viking Therapeutics Inc (NASDAQ: VKTX) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.8%
4/3 Form 4 Viking Therapeutics, For: Mar 31 Filed by: MORNEAU MICHAEL 5.4%
11/12 Viking Therapeutics to Participate in Upcoming Investor Conferences 4.9%
10/31 Form 4 Viking Therapeutics, For: Oct 31 Filed by: MORNEAU MICHAEL 4.7%
3/17 Form 8-K Viking Therapeutics, For: Mar 17 3.7%
7/15 Viking Therapeutics Inc (NASDAQ: VKTX) is now covered by analysts at Citigroup Inc. They set an "outperform" rating on the stock. 3.5%
8/6 Viking Therapeutics Inc (VKTX) Q2 2019 Earnings Call Transcript [The Motley Fool] 2.6%
3/19 Viking Therapeutics Inc (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at William Blair. 8.1%
5/4 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.2%
12/21 Viking Therapeutics Inc (NASDAQ: VKTX) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.8%
4/3 Form 4 Viking Therapeutics, For: Mar 31 Filed by: MORNEAU MICHAEL 5.4%
11/12 Viking Therapeutics to Participate in Upcoming Investor Conferences 4.9%
10/31 Form 4 Viking Therapeutics, For: Oct 31 Filed by: MORNEAU MICHAEL 4.7%
3/17 Form 8-K Viking Therapeutics, For: Mar 17 3.7%
7/15 Viking Therapeutics Inc (NASDAQ: VKTX) is now covered by analysts at Citigroup Inc. They set an "outperform" rating on the stock. 3.5%
8/6 Viking Therapeutics Inc (VKTX) Q2 2019 Earnings Call Transcript [The Motley Fool] 2.6%
TOP News Decliners
11/19
Viking launches mid-stage study of VK2809 in NASH; shares up 7% premarket [Seeking Alpha]
-15.5%
3/21 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -9.0%
1/3 Form 4 Viking Therapeutics, For: Jan 02 Filed by: SINGLETON J MATTHEW -9.0%
2/26 Form 10-K Viking Therapeutics, For: Dec 31 -8.7%
5/28 Viking Therapeutics to Participate in Upcoming Investor Conferences -8.2%
5/1 Viking Therapeutics Inc (NASDAQ: VKTX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $9.00 price target on the stock. -7.6%
8/11 Is Viking Therapeutics a Buy? [The Motley Fool] -7.3%
8/1 Q2/2019 6/30/2019 EPS -0.110 ZacksConsensus -0.090 ActVsEst (0.020) - Miss -6.6%
5/7 3 Top Biotech Stocks to Buy in May [The Motley Fool] -6.2%
4/14 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
3/21 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -9.0%
1/3 Form 4 Viking Therapeutics, For: Jan 02 Filed by: SINGLETON J MATTHEW -9.0%
2/26 Form 10-K Viking Therapeutics, For: Dec 31 -8.7%
5/28 Viking Therapeutics to Participate in Upcoming Investor Conferences -8.2%
5/1 Viking Therapeutics Inc (NASDAQ: VKTX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $9.00 price target on the stock. -7.6%
8/11 Is Viking Therapeutics a Buy? [The Motley Fool] -7.3%
8/1 Q2/2019 6/30/2019 EPS -0.110 ZacksConsensus -0.090 ActVsEst (0.020) - Miss -6.6%
5/7 3 Top Biotech Stocks to Buy in May [The Motley Fool] -6.2%
4/14 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: